Top Analyst Upgrades & Downgrades (AMGN, CS, BEAT, DV, MAR, MSFT, RIMM, SPWRA, TOL)

Investing

Published: April 24, 2009 6:30 am

These are among the top research calls and analyst upgrades and downgrades we have seen early this Friday morning with over two hours until the open:

Amgen (AMGN) Raised to Outperform at Baird.
Credit Suisse (CS) Raised to Neutral at UBS.
CardioNet (BEAT) Started as Underperform at Jefferies.
Devry (DV) Cut to Neutral at Baird.
Marriott (MAR) Cut to Market Perform at FBR.
Microsoft (MSFT) Raised to Overweight at Morgan Stanley.
Research In Motion (RIMM) Raised to Buy at Citigroup.
Sunpower (SPWRA) Cut to Sell from Neutral at Merriman Curhan Ford.
Toll Brothers Inc. (TOL) Cut to Market Perform at KBW.

JON C. OGG

Travel Cards Are Getting Too Good To Ignore

Credit card companies are pulling out all the stops, with the issuers are offering insane travel rewards and perks.

We’re talking huge sign-up bonuses, points on every purchase, and benefits like lounge access, travel credits, and free hotel nights. For travelers, these rewards can add up to thousands of dollars in flights, upgrades, and luxury experiences every year.

It’s like getting paid to travel — and it’s available to qualified borrowers who know where to look.

We’ve rounded up some of the best travel credit cards on the market. Click here to see the list. Don’t miss these offers — they won’t be this good forever.